Novartis funds independent educational programs for US healthcare professionals on Sjögren's Disease and GEP NET to address knowledge gaps and improve patient care.
Funder: Novartis
Due Dates: June 29, 2026 (Sjögren's Disease) | July 31, 2026 (GEP NET) | August 14, 2026 (GEP NET)
Funding Amounts: Up to $400,000 total for Sjögren's Disease RFP (max $300,000 per initiative); up to $350,000 total for GEP NET RFP.
Summary: Supports independent, high-quality educational programs for US healthcare professionals focused on specific disease areas to advance patient care.
Key Information: Applications must be submitted via Novartis Grants Central Station by 5 PM EST on the listed due dates.
Novartis Professional Medical Education Grants provide support for independent educational programs aimed at US healthcare professionals, with the goal of improving patient care in targeted therapeutic areas. These grants fund live events, web-based education, and enduring materials, provided all activities are free of commercial bias and non-promotional. Current Requests for Proposals (RFPs) focus on Sjögren's Disease and Gastroenteropancreatic Neuroendocrine Tumors (GEP NET), seeking innovative continuing medical education (CME) initiatives that address critical knowledge gaps and clinical challenges. Eligible activities include symposia, workshops, curriculum-based education, and quality improvement collaboratives, among other formats.